AstraZeneca’s COVID-19 vaccine Vaxzevria is no longer being manufactured or supplied due to declining demand, the company said Wednesday.
It is also withdrawing the vaccine’s authorization to be marketed or sold in countries that are part of the European Union, AstraZeneca said.
“As multiple variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied,” the company told Global News in an email Wednesday.
“AstraZeneca has therefore taken the decision to initiate withdrawal of the Marketing Authorizations for Vaxzevria within Europe.”
Alongside Pfizer-BioNTech and Moderna, AstraZeneca’s Vaxzevria was one of three primary vaccines administered worldwide against COVID-19 beginning in 2021.
However, safety concerns arose in March 2021 when Canada’s National Advisory Committee on Immunization(NACI) recommended the vaccine not be administered to people under age 55 following reports of blood …